Independent research · not medical adviceSources dated · terms can change

Comparison guide · source-checked guide

How to itemize online GLP-1 fees before you enroll

By Izaiah Tilton · Independent research · every claim source-cited · updated 2026-07-23

Generated editorial evidence map for How to itemize online GLP-1 fees before you enroll

Quick answer

Ask every program for the same itemized quote: intake, membership, clinician care, medication, labs, supplies, shipping, and cancellation or renewal obligations. Record the amount due now, each recurring charge, and the full minimum-term total. Keep annual-plan rates, variable prices, insurance help, HSA/FSA language, and missing fields attached to the number they qualify.

Compare your priorities privately

Verified claims

Each statement below is bound to its numbered source.

  1. The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.123456
  2. Compounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality.78
  3. Unexpected material connections should be disclosed clearly and conspicuously.9

Facts to compare

Source-bound facts from this guide
QuestionPublished factEvidence
CostThe six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Mapped claim
Product statusCompounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality.Mapped claim

What to verify

Confirm

  • A common fee table reveals what each starting price includes or leaves unresolved.
  • First-month and minimum-term totals make longer commitments visible.
  • Dated first-party evidence can be checked again when terms change.

Do not assume

  • Important fees or cancellation terms may remain unclear until checkout or direct inquiry.
  • Quotes for different products, service bundles, or insurance paths are not interchangeable.
  • A saved quote needs a fresh check when price or terms change.

Quick evidence check

What the sources establish

  • A common fee table reveals what each starting price includes or leaves unresolved.
  • First-month and minimum-term totals make longer commitments visible.
  • Dated first-party evidence can be checked again when terms change.

What still needs verification

  • Important fees or cancellation terms may remain unclear until checkout or direct inquiry.
  • Quotes for different products, service bundles, or insurance paths are not interchangeable.
  • A saved quote needs a fresh check when price or terms change.

Provider facts side by side

Published program terms and normalized evidence scores; unsupported fields are omitted rather than shown as zero.
ProviderStarting priceMedications offeredInsuranceAverage waitClinic Scout scorePublic review signalNext steps
FoundCompounded options advertised from $99/month; membership and medication costs may be separateBranded and compounded prescription options; availability and eligibility varyFree insurance check and carrier support are described; coverage remains plan-specificMany members may start within a week; not guaranteed7.8/10
yourEraCompounded semaglutide from $99/month; compounded tirzepatide from $169/monthCompounded semaglutide and compounded tirzepatideSelf-pay; no insurance required; HSA/FSA treatment depends on the administratorNot stated7.6/10
TrimiCompounded semaglutide from $99/month and compounded tirzepatide from $125/month on annual plansCompounded semaglutide and compounded tirzepatideSelf-pay; states HSA/FSA eligibilityNot stated7.5/10
ShedGLP-1 injection program advertised from $199/month; medication and dose may change priceBranded and compounded GLP-1 options; prescription and availability varyInsurance or cash-pay options are described; support is not a coverage guaranteeNot stated7.1/10
Gala GLP-1Compounded GLP-1/GIP advertised from $179/month on a yearly subscription planCompounded GLP-1/GIP and selected branded optionsSelf-pay; insurance not requiredNot stated6.5/10
Oak LongevityProgram advertised from $119/month; page metadata exposes other figures, so checkout verification is requiredSemaglutide and tirzepatide options are describedInsurance process is not stated clearly enough to treat as coverage supportNot stated6.2/10

Start with one fee table for every program

Provider pages rarely arrange fees in the same order. One leads with medication, another with membership, and another with a normalized annual rate. Start with your own blank table instead. Asking every program for the same categories makes omissions and mismatched service bundles visible before a low headline number sets the comparison.

How to record unknown or changing fees

Require a written source for each amount. The ideal evidence is the current official product page plus the prepayment checkout summary, terms, and a dated support response for anything ambiguous. A search result, coupon site, testimonial, or old article can suggest a question but should not set the number in the table. The provider information was checked on 2026-07-23 and therefore serves as a dated starting point, not a promise that any price remains available.

Do not write zero for an unstated fee. For example, Gala's reviewed evidence described a nationwide pharmacy network but did not state the shipping fee; the table should say "not stated." Found's reviewed source says medication and membership or clinical-care pricing may be separate; the table should request both. Oak's page details exposed differing price points; the table should use the current checkout quote, not whichever number is lower. Unknowns are decision-relevant evidence.

Turn a monthly rate into the full obligation

Every quote needs four timing fields: amount due today, recurring amount, billing cadence, and full minimum-term obligation. Trimi's lowest advertised prices were tied to an annual plan, and Gala's $179 starting figure was tied to a yearly subscription. A per-month normalization can be accurate while still hiding the contract's financial exposure. Ask whether the amount is prepaid or billed in installments, when it renews, and what charges remain after cancellation.

Compare the first month and full minimum term separately. This prevents a month-to-month or uncertain-duration offer from being ranked against an annual-plan rate without a qualifier. It also exposes onboarding or initial fees that a later recurring price may omit. If the provider will not state a minimum obligation before payment, mark commitment clarity as a con. Do not assume favorable cancellation, pause, refund, or renewal terms that are absent from the reviewed source.

Price-change conditions deserve their own field. Shed's reviewed source says medication and dose can change price. Found says medication and membership or clinical-care costs vary. Product availability and eligibility can also affect quotes. Record which event can change the amount, when notice is provided, and whether the consumer can decline. A range or variable field is not a flaw by itself, but it must not be presented as a fixed all-in total.

Define what care the price includes

Provider pages describe different service bundles. Found mentions clinician assessment review and monthly check-ins. yourEra describes licensed-provider intake review and ongoing care-team messaging. Trimi describes licensed-provider review through Arora Health. Shed describes provider-led care, follow-ups, and health coaching. Gala describes state-licensed provider review. Oak describes doctor review of submitted information. These statements show that a service process exists; they do not prove identical access, cadence, or value.

Turn each broad service statement into fee questions. How many scheduled contacts are included? Is messaging included or charged separately? Is coaching part of the starting amount? Are labs required, and if so who bills them? Are supplies included? What happens if additional review is requested? Keep the questions operational. This no-clinician guide cannot assess whether a care model is medically better, and it does not claim that more contacts produce better outcomes.

Average wait time was not stated for yourEra, Trimi, Shed, or Gala in the reviewed source, and Found's statement that many members can start within a week is not guaranteed. Do not infer service speed from shipping method. Trimi's free overnight shipping can be recorded as shipping specificity, not an intake-to-start promise. Ask for the current timeline by stage and avoid paying an expedited premium unless its scope and refund terms are clear.

Check shipping, location, and payment support separately

Shipping is one of the easier fees to verify, but the sources still differ. yourEra and Shed state free shipping, Trimi states free overnight shipping, Oak states free tracked delivery, Found says medication ships when prescribed without a fee fact in the reviewed source, and Gala does not state a shipping fee in the reviewed evidence. Record only the sourced statement. Also ask whether supplies, replacement shipments, damaged packages, and address changes can generate costs.

Service area can change whether a quote is usable. yourEra and Trimi state all-50-state availability; Gala states licensed providers in all 50 states; Found is available only in listed states; Shed's service area was not fully enumerated; and Oak's was not stated. A national statement does not guarantee every product in every state or individual eligibility. Confirm the exact service and product for the consumer's location before treating the quote as actionable.

Payment-support language must remain distinct from price. Found's free insurance check and Shed's insurance-or-cash-pay options may help a consumer explore benefits, but they do not guarantee coverage. yourEra's HSA/FSA use may depend on an administrator, and Trimi's HSA/FSA statement likewise should be verified. Put insurer responsibility, self-pay charges, and possible account use in separate fields. Combining them can make the provider fee look lower than the consumer's real economic cost.

Keep unlike product categories in separate rows

The provider fee table must identify whether the quote involves a branded FDA-approved product or a compounded product. Found and Shed describe both branded and compounded pathways, while yourEra and Trimi list compounded semaglutide and compounded tirzepatide, and Gala describes compounded plus selected branded options. Oak describes semaglutide and tirzepatide options, but its reviewed source excludes a same-active-ingredient equivalence claim. Do not collapse these descriptions into one interchangeable product row.

FDA states that compounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality. That fact belongs beside compounded quotes so a low fee is not mistaken for regulatory equivalence. The fee comparison must not claim that a compounded product is a generic equivalent, safer, less safe, more effective, or less effective based on price. Those are not supported commercial conclusions, and treatment decisions require a qualified healthcare professional.

Product labels also protect the accuracy of a cheapest-option claim. A branded insured quote, a compounded self-pay annual rate, and a variable-dose program may all have different totals, but ranking them as equivalent purchases would mislead. Either compare within the same clearly defined category or present parallel scenarios without one overall winner. If the exact product is unknown until review, label the quote provisional and delay the ranking.

Use missing terms as part of the verdict

A fee comparison can score transparency without pretending to score medical quality. Award commercial clarity for a published product-specific amount, explicit commitment, clear included services, stated shipping fee, documented payment pathway, and current cancellation terms. Deduct or flag uncertainty for variable pricing without a range, conflicting metadata, separate unstated fees, missing service area, or an unclear minimum obligation. Do not award points for testimonials, outcome percentages, or promotional superlatives.

The provider examples yield genuine cons. Found may separate medication and care costs. yourEra leaves average wait unstated and HSA/FSA use administrator-dependent. Trimi's lowest rates require an annual plan. Shed's price can vary with medication or dose and its service area needs verification. Oak exposes differing starting-price figures and does not state service area. Gala's yearly-plan figure comes with an unstated shipping fee. A commercial relationship does not remove any of those limitations.

Reconcile the invoice and set an update trigger

Close the process by saving the itemized quote, checkout summary, terms, cancellation method, and dated provider answers. Recalculate before renewal. Finally, keep the boundary: this checklist compares fees and terms only. It cannot determine eligibility, product choice, risks, or treatment. When the rows are not comparable or material fields remain unknown, decline to name a cheapest provider.

Add a reconciliation step after the first invoice. Compare every line against the saved quote and note whether the charge was expected, variable within a disclosed rule, or unexplained. Contact the provider promptly about unexplained differences and retain the written response. This turns fee comparison into an ongoing control rather than a one-time shopping exercise. It also reveals whether an apparently clear offer remains clear after fulfillment without using a testimonial or generalizing one consumer's experience into a provider-wide claim.

Finally, establish an update trigger. Reopen the comparison when the product, dose, insurance path, membership tier, state, shipping terms, or renewal date changes. Use the newest official source and archive the prior version rather than overwriting the evidence trail. A fee verdict should expire when its inputs change. That rule may prevent a permanent ranking, but it produces a more honest commercial guide and reduces the chance that a dated "from" price becomes an unsupported current promise. Assign every comparison a next-review date even when no change is reported. On that date, confirm each source URL still resolves, capture the current price qualifier, and check whether a previously unstated fee now appears. If the evidence cannot be refreshed, remove the specific fee verdict rather than carrying it forward on trust.

Sources and what they support

  1. FoundSupports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  2. yourEraSupports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  3. TrimiSupports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  4. ShedSupports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  5. Oak LongevitySupports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  6. Gala GLP-1Supports: The six first-party provider records support the cited starting prices, qualifiers, service descriptions, shipping statements, payment pathways, and missing fields used in this checklist.Open sourceChecked 2026-07-23
  7. U.S. Food and Drug AdministrationSupports: Compounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality.Open sourceChecked 2026-07-23
  8. U.S. Food and Drug AdministrationSupports: Compounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality.Open sourceChecked 2026-07-23
  9. Federal Trade CommissionSupports: Unexpected material connections should be disclosed clearly and conspicuously.Open sourceChecked 2026-07-23

Turn the research into a shortlist

Use the private fit quiz to compare cost, support, and verification priorities without sending health details to providers.

Start the fit quiz